T1	Age 2 13	77-year-old
T2	Sex 14 19	woman
T3	Clinical_event 35 44	presented
E1	Clinical_event:T3 
T4	Sign_symptom 25 34	dysphagia
E2	Sign_symptom:T4 
T5	Duration 52 68	two-week history
E3	Duration:T5 
T6	Sign_symptom 72 76	rash
E4	Sign_symptom:T6 
T7	Sign_symptom 100 107	plaques
E5	Sign_symptom:T7 
T8	Color 94 99	brown
R1	MODIFY Arg1:T8 Arg2:E5	
T9	Detailed_description 113 133	erythematous borders
R2	MODIFY Arg1:T9 Arg2:E5	
T10	Detailed_description 138 160	overlying thick scales
R3	MODIFY Arg1:T10 Arg2:E5	
T11	Biological_structure 175 179	face
R4	MODIFY Arg1:T11 Arg2:E5	
T12	Sign_symptom 281 292	involvement
E6	Sign_symptom:T12 
A1	POLARITY E6 NEG
T13	Biological_structure 260 264	oral
T14	Biological_structure 268 280	conjunctival
R5	MODIFY Arg1:T14 Arg2:E6	
R6	MODIFY Arg1:T13 Arg2:E6	
T15	Diagnostic_procedure 192 227	percutaneous endoscopic gastrostomy
E7	Diagnostic_procedure:T15 
T16	Diagnostic_procedure 229 232	PEG
E8	Diagnostic_procedure:T16 
R7	IDENTICAL Arg1:E8 Arg2:E7	
T17	Biological_structure 239 243	site
R8	MODIFY Arg1:T17 Arg2:E5	
R9	CAUSE Arg1:E7 Arg2:T17	
#1	AnnotatorNotes T17	The Diagnostic_procedure modifies the site here because the site only exists due to the procedure
T18	Medication 329 349	parenteral nutrition
E9	Medication:T18 
T19	Duration 354 364	two months
E10	Duration:T19 
T20	Diagnostic_procedure 390 398	PEG tube
E11	Diagnostic_procedure:T20 
A2	POLARITY E11 NEG
T21	Disease_disorder 406 415	infection
E12	Disease_disorder:T21 
T22	Disease_disorder 462 483	drug hypersensitivity
E13	Disease_disorder:T22 
A3	POLARITY E13 UNCERTAIN
T23	Disease_disorder 485 505	autoimmune disorders
E14	Disease_disorder:T23 
A4	POLARITY E14 UNCERTAIN
T24	Disease_disorder 510 532	nutritional deficiency
E15	Disease_disorder:T24 
A5	POLARITY E15 UNCERTAIN
T25	Sign_symptom 538 542	rash
E16	Sign_symptom:T25 
T26	Disease_disorder 579 607	acrodermatitis enteropathica
E17	Disease_disorder:T26 
T27	Disease_disorder 635 650	zinc deficiency
E18	Disease_disorder:T27 
R10	CAUSE Arg1:E18 Arg2:E17	
T28	Sign_symptom 613 621	eruption
E19	Sign_symptom:T28 
T29	Diagnostic_procedure 662 666	zinc
E20	Diagnostic_procedure:T29 
T30	Detailed_description 656 661	serum
R11	MODIFY Arg1:T30 Arg2:E20	
T31	Lab_value 677 686	12 mcg/dL
R12	MODIFY Arg1:T31 Arg2:E20	
T32	Sign_symptom 720 724	rash
E21	Sign_symptom:T32 
A6	POLARITY E21 NEG
T33	Date 734 749	within one week
E22	Date:T33 
T34	Medication 764 784	zinc supplementation
E23	Medication:T34 
T35	Administration 753 763	parenteral
R13	MODIFY Arg1:T35 Arg2:E23	
R14	BEFORE Arg1:E2 Arg2:E1	
R15	AFTER Arg1:E1 Arg2:E3	
*	OVERLAP E3 E4 E5
R16	AFTER Arg1:E5 Arg2:E7	
R17	BEFORE Arg1:E7 Arg2:E6	
R18	AFTER Arg1:E6 Arg2:E9	
*	OVERLAP E9 E10
R19	AFTER Arg1:E10 Arg2:E11	
*	OVERLAP E11 E12
R20	BEFORE Arg1:E12 Arg2:E13	
*	OVERLAP E13 E14 E15 E16 E17 E19 E18 E20
R21	BEFORE Arg1:E20 Arg2:E21	
*	OVERLAP E21 E22 E23 E24
T36	Other_event 1275 1311	national shortage of parenteral zinc
E24	Other_event:T36 
T37	Nonbiological_location 1319 1332	United States
R22	MODIFY Arg1:T37 Arg2:E24	
